You are here:
Home
NICE Guidance
NICE Advice
Evidence summaries
Type 2 diabetes: lixisenatide
Evidence summary
Reference number:
ESNM26
Published:
24 September 2013
This evidence summary has been updated and replaced by
NICE guideline NG28
.
Back to top